How does tumour heterogeneity arise? How can we predict cancer cell plasticity? In 2 new studies, we trace #glioblastoma heterogeneity to a spatial cancer cell trajectory w. multimodal cell atlassing bit.ly/4mkrWgs & predict plasticity w. snRNA/ATAC+deep learning bit.ly/3FbI6Ic π§΅
16.05.2025 11:42 β π 71 π 31 π¬ 6 π 5
Our experience with the multimodal seg is similar as yours- works great for many cell types or tissues, but not all.
Plus there can be contaminating transcripts on top.
26.03.2025 19:47 β π 0 π 0 π¬ 0 π 0
Thank you! Yes, we believe segger has an edge over membrane-based segmentation because it also recognises the co-occurrence of transcripts. You can also use 10x multi-modal instead of nuclear segmentation as seggers input.
26.03.2025 19:45 β π 1 π 0 π¬ 1 π 0
Some classical statistics today.
ebmstate, an R package for multistate models with empirical Bayes covariate effect estimation.
Developed by Rui Costa during his postdoc in my group.
doi.org/10.32614/RJ-...
20.03.2025 14:03 β π 4 π 0 π¬ 1 π 0
Segger logo
Message passing intuition behind the seggerβs link-prediction model and the network architecture
1/ New preprint! π³
@elihei.bsky.social and our team at @embl.org , @dkfz.bsky.social, and @mskcancercenter.bsky.social built #segger - a fast, accurate cell segmentation tool for spatial transcriptomics that assigns transcripts to their cell origins!
doi.org/10.1101/2025...
18.03.2025 14:48 β π 65 π 22 π¬ 2 π 4
Also tagging Elyas Heidari @elihei.bsky.social here who led this fantastic work.
18.03.2025 10:22 β π 0 π 0 π¬ 0 π 0
A great thanks goes to all the other authors and contributors from the Gerstung, Stegle and Peer labs who made this work possible.
17.03.2025 16:18 β π 1 π 0 π¬ 1 π 0
Andrew Moorman and other members of @danapeer.bsky.social's lab helped carry out a rigorous assessment based on various 10x Xenium data sets with bespoke segmentation stainings, providing the ground truth to demonstrate segger's superior performance.
17.03.2025 16:18 β π 4 π 0 π¬ 1 π 0
Segger is a super fast graph neural network algorithm, which makes cell segmentation much more reliable and faster.
17.03.2025 16:18 β π 3 π 0 π¬ 1 π 0
Spatial transcriptomics holds great promise to understand biological tissue function, but the assignment of transcripts to cells has been a substantial bottleneck.
For this reason, Elyas Heidari, a student in my lab and in @steglelab.bsky.social built segger.
www.biorxiv.org/content/10.1...
17.03.2025 16:18 β π 51 π 18 π¬ 3 π 1
Evidence Aggregator: AI reasoning applied to rare disease diagnostics
Retrieving, reviewing, and synthesizing technical information can be time-consuming and challenging, particularly when requiring specialized expertise, as is the case of variant assessment for rare di...
New preprint! We worked with @msftresearch.bsky.social and @broadinstitute.org to see whether large language models (LLMs) can be useful to variant scientists in deciding whether genetic variants seen in a patient are responsible for their disease. tl;dr yes they can: www.biorxiv.org/content/10.1...
15.03.2025 02:43 β π 143 π 47 π¬ 2 π 1
Amazing work. Weβre all walking laboratories for somatic evolution.
20.11.2024 19:25 β π 8 π 0 π¬ 0 π 0
Somatic mutation and selection at epidemiological scale
As we age, many tissues become colonised by microscopic clones carrying somatic driver mutations ([1][1]β[10][2]. Some of these clones represent a first step towards cancer whereas others may contribu...
Resharing here a recent X post. In this preprint, we introduce an improved version of NanoSeq, a duplex sequencing protocol with <5 errors per billion bp in single DNA molecules, and use it to study the somatic mutation landscape of oral epithelium in >1000 people. 1/ www.medrxiv.org/content/10.1...
20.11.2024 14:27 β π 88 π 38 π¬ 2 π 4
Safe travels! Weβre still waiting for the snow you got yesterday to arrive but chances look slim. Probably better travel wise.
20.11.2024 06:09 β π 6 π 0 π¬ 0 π 0
Thanks. Was on a bit of a social media hiatus, but this place looks like a new hope.
18.11.2024 17:20 β π 2 π 0 π¬ 1 π 0
Congratulations! Looking forward to seeing the outputs of your scientific ingenuity becoming multiplied.
18.11.2024 17:15 β π 0 π 0 π¬ 1 π 0
Example Paion report for a confirmed myxopapillary ependymoma diagnosis. Shown are H&E, prediction heatmaps and automatically selected representative image tiles.
3/3 Paion is a new algorithm to diagnose brain cancers from H&E images.
* distinguishes 102 types of brain cancer
* high confidence predictions in 50-70% of cases across 7 cohorts
* top1 acc > 85% in high conf subset
* 2 day turnaround v 3 weeks for molecular testing
Preprint coming soon.
18.11.2024 08:20 β π 2 π 0 π¬ 0 π 0
2/3 Delphi-2M generative AI model for multi-disease risks
* a single GPT-derived model learns risks of 1257 diseases
* samples future life courses
* offers insights into multi-morbidity dynamics
www.medrxiv.org/content/10.1...
18.11.2024 08:20 β π 2 π 1 π¬ 1 π 0
5:20 start this morning for a virtual talk at the WEHI in Melbourne, covering:
* Cancer risk models
* Delphi multi-disease genAI
* Paion, a new brain tumor digital pathology algorithm
Summary below:
18.11.2024 08:20 β π 11 π 1 π¬ 2 π 0
New at Science
Evo, a large language of life (LLLM) genomic foundation model, predicting & generating tasks from molecular to genomic scale
science.org/doi/10.1126/...
14.11.2024 19:16 β π 208 π 40 π¬ 3 π 1
Delphi is cool: nanoGPT, adapted to generate (clinical ontology term, waiting time) tuples i.e. a continuous time Markov chain on clinical ontology terms, trained on patient histories. Predicts conditions on par with clinical indicators in current practice.
15.11.2024 14:42 β π 0 π 1 π¬ 0 π 0
Research group leader @German Cancer Research Center, reconstructing human development and disease using cell fate engineering
Elihu Professor of Biostatistics @yalesph.bsky.social--Cancer, Infectious disease, Evolutionary biology, Fungi, sometimes running
We are Data Scientists & Architects in Cancer Research.
The German Cancer Research Center is matrix structured, with 5 research topics & cross topics. Our cross topic boosts cancer research by driving next level AI methods & data science in all domains.
Scientist at DKFZ and EMBL in Heidelberg, loving stats, genomics and genetics. @OliverStegle@genomic.social. For group news see @steglelab.bluesky.social
Bioinformatics research group leader at the Berlin Institute of Health, ELIXIR and de.NBI. Main focus: cancer, immunology, placenta, and all things omics... especially spatial omics.
Helmholtz Junior Research Group at DKFZ, Germany, interested in stem cell biology, DNA replication stress, and the combination of these in brain genome mosaicism.
Assistant Prof @ NYU Grossman School of Medicine | alumna @BroadInstitute @VertexPharma @sangerinstitute | Somatic mosaicism in cancer & aging π»π¬ Opinions my own.
Group Leader, Genome Institute of Singapore, A*STAR, Working on computational methods for long read RNA-Seq
https://github.com/goekelab
Physician Scientist at MSK. All views expressed here are my own & do not represent my employer. COI:http://bit.ly/2LQCLKe
Genetics, bioinformatics, comp bio, statistics, data science, open source, open science!
Prof at U of Colorado SOM. Researcher in the evolutionary biology of cancer, AML, and aging. Completely dog-dependent. Waiting for the next puzzling result....
Research, news, and commentary from Nature, the international science journal. For daily science news, get Nature Briefing: https://go.nature.com/get-Nature-Briefing
Nature Reviews Cancer is a monthly review journal for researchers working on cancer. We, the editors, highlight the most exciting topics in cancer research.
https://www.nature.com/nrc/
Nationales Centrum fΓΌr Tumorerkrankungen (NCT) Heidelberg - eine gemeinsame Einrichtung des Deutschen Krebsforschungszentrums (DKFZ), des UniversitΓ€tsklinikums Heidelberg (UKHD), der Medizin. FakultΓ€t HD der Uni Heidelberg und der Thoraxklinik Heidelberg.
Publishing the latest advances across all areas of cancer research and oncology. Part of @natureportfolio.nature.com
π www.nature.com/natcancer/
πNew York, London, Berlin and Heidelberg
Science Director of OpenTargets and Group Leader at Wellcome Sanger Institute
Genetics, immunology, drug discovery
Outdoors, cats, dogs and all animals
Views are my own
CAIO | Professor | Founder
The 'Immunology, Infection and Cancer' research program at the DKFZ in Heidelberg focuses on the interactions between pathogens and the immune system and how they drive carcinogenesis with the aim to develop novel immunotherapeutic approaches to cancer.